AMGEN (AMGN) has a profit margin of 22.95%, above the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), AMGN shows a profit margin of 22.95%. That compares with 18.96% in the prior-year period — up 21.0% year over year. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AMGN's profit margin is now 22.95% (was 18.96%) — a 21.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AMGEN is outperforming or lagging.
The Healthcare sector average profit margin is about 21.34%. AMGEN is at 22.95%, which is higher that average. That is roughly 7.6% above the sector mean. Use the comparison chart on this page to see how AMGN stacks up against individual peers as well.
That compares with 18.96% in the prior-year period — up 21.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare AMGEN with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has AMGEN's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 22.95%) with ownership activity and broader fundamentals.